Neostigmine methylsulfate 0.5 MG/ML Injectable Solution — RxCUI 311935
RxNorm drug concept · Semantic clinical drug
RxCUI 311935
Semantic clinical drug · SCD
● Current RxNorm concept 39 FDA products
45 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311935
Official nameNeostigmine methylsulfate 0.5 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped39
Package NDCs mapped45
Reported Medicaid activity (SDUD)6,048 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Neostigmine Methylsulfate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- During surgery, you may be given a muscle relaxant to keep your muscles completely still — including your breathing muscles. When the procedure is over, the care team needs those m...
- What exactly does neostigmine methylsulfate do during or after surgery?
- Neostigmine is given directly into a vein by the anesthesia team, so you won't feel a needle stick in the usual sense. Some people experience nausea, increased saliva, or a slow or...
- Yes — it's important to tell your anesthesia team if you have heart disease, irregular heart rhythms, or had a recent heart attack, because neostigmine can affect your heart rate a...
🕸️ Concept Web — How Neostigmine methylsulfate 0.5 MG/ML Injectable S... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Neostigmine methylsulfate 0.5 MG/ML Injectable Solution
RxCUI 311935 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Neostigmine
7315IN -
Neostigmine methylsulfate
7316PIN
-
Neostigmine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bloxiverz
1429278BN
-
Bloxiverz
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Neostigmine Injectable Solution
373043SCDF -
Neostigmine methylsulfate Injectable Solution
2647582SCDFP -
Neostigmine Injectable Product
1157557SCDG -
Neostigmine methylsulfate Injectable Product
2659497SCDGP -
Neostigmine Injectable Solution [Bloxiverz]
1429280SBDF -
Neostigmine methylsulfate Injectable Solution [Bloxiverz]
2658583SBDFP -
Bloxiverz Injectable Product
1429281SBDG -
Injectable Solution
316949DF - +1 more in this family
-
Neostigmine Injectable Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Neostigmine methylsulfate 0.5 MG/ML
1649889SCDC -
Neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
1429282SBD -
Neostigmine methylsulfate 0.5 MG/ML [Bloxiverz]
1649891SBDC
-
Neostigmine methylsulfate 0.5 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Neostigmine methylsulfate 0.5 MG/ML
SCDC · 1649889 -
Neostigmine Injectable Solution
SCDF · 373043 -
Neostigmine methylsulfate Injectable Solution
SCDFP · 2647582 -
Neostigmine Injectable Product
SCDG · 1157557 -
Neostigmine methylsulfate Injectable Product
SCDGP · 2659497
Brand-Name Concepts
-
Neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]
SBD · 1429282 -
Neostigmine methylsulfate 0.5 MG/ML [Bloxiverz]
SBDC · 1649891 -
Neostigmine Injectable Solution [Bloxiverz]
SBDF · 1429280 -
Neostigmine methylsulfate Injectable Solution [Bloxiverz]
SBDFP · 2658583 -
Bloxiverz Injectable Product
SBDG · 1429281 -
Bloxiverz
BN · 1429278
📦 FDA Products & Package NDCs
39 products · 45 package NDCs
45 package NDCs map to RxCUI 311935 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00548-9601-00 | 10 CARTON in 1 PACKAGE (0548-9601-00) / 1 VIAL, MULTI-DOSE... | NEOSTIGMINE METHYLSULFATE | Amphastar Pharmaceuticals, Inc. | 2017-09-25 |
| 00548-9602-00 | 10 CARTON in 1 PACKAGE (0548-9602-00) / 1 VIAL, MULTI-DOSE... | NEOSTIGMINE METHYLSULFATE | Amphastar Pharmaceuticals, Inc. | 2017-09-25 |
| 00641-6149-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0641-6149-10) / 10 mL in 1... | Neostigmine Methylsulfate | Hikma Pharmaceuticals USA Inc. | 2015-12-28 |
| 00641-6150-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0641-6150-10) / 10 mL in 1... | Neostigmine Methylsulfate | Hikma Pharmaceuticals USA Inc. | 2015-12-28 |
| 00641-6264-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0641-6264-10) / 10 mL in 1... | Neostigmine Methylsulfate | Hikma Pharmaceuticals USA Inc. | 2015-12-28 |
| 00641-6265-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0641-6265-10) / 10 mL in 1... | Neostigmine Methylsulfate | Hikma Pharmaceuticals USA Inc. | 2015-12-28 |
| 14445-0413-01 | 10 CARTON in 1 PACKAGE (14445-413-01) / 1 VIAL, MULTI-DOSE... | NEOSTIGMINE METHYLSULFATE | Indoco Remedies Limited | 2021-11-26 |
| 14445-0414-01 | 10 CARTON in 1 PACKAGE (14445-414-01) / 1 VIAL, MULTI-DOSE... | NEOSTIGMINE METHYLSULFATE | Indoco Remedies Limited | 2021-11-26 |
| 23155-0517-41 | 10 VIAL in 1 CARTON (23155-517-41) / 10 mL in 1 VIAL (23155... | Neostigmine Methylsulfate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-11-25 |
| 23155-0518-41 | 10 VIAL in 1 CARTON (23155-518-41) / 10 mL in 1 VIAL (23155... | Neostigmine Methylsulfate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-11-25 |
| 25021-0610-10 | 10 VIAL in 1 CARTON (25021-610-10) / 10 mL in 1 VIAL | Neostigmine Methylsulfate | Sagent Pharmaceuticals | 2022-01-15 |
| 25021-0611-10 | 10 VIAL in 1 CARTON (25021-611-10) / 10 mL in 1 VIAL | Neostigmine Methylsulfate | Sagent Pharmaceuticals | 2022-01-15 |
| 42023-0188-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (42023-188-10) / 10 mL in 1... | NEOSTIGMINE METHYLSULFATE | Par Health USA, LLC | 2017-04-26 |
| 42023-0189-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (42023-189-10) / 10 mL in 1... | NEOSTIGMINE METHYLSULFATE | Par Health USA, LLC | 2017-04-26 |
| 43598-0528-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11) / 10 mL in 1... | Neostigmine | Dr.Reddy's Laboratories Inc | 2018-09-04 |
| 43598-0528-36 | 10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36) / 10 mL in 1... | Neostigmine | Dr.Reddy's Laboratories Inc | 2018-09-04 |
| 43598-0529-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-529-11) / 10 mL in 1... | Neostigmine | Dr.Reddy's Laboratories Inc | 2018-09-04 |
| 43598-0529-36 | 10 VIAL, MULTI-DOSE in 1 CARTON (43598-529-36) / 10 mL in 1... | Neostigmine | Dr.Reddy's Laboratories Inc | 2018-09-04 |
| 51754-1200-03 | 10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1... | Bloxiverz | Exela Pharma Sciences, LLC | 2023-12-31 |
| 55150-0348-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-348-10) / 10 mL in 1... | NEOSTIGMINE METHYLSULFATE | Eugia US LLC | 2023-11-02 |
| 55150-0349-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-349-10) / 10 mL in 1... | NEOSTIGMINE METHYLSULFATE | Eugia US LLC | 2023-11-02 |
| 63323-0413-10 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-10) / 10 mL in 1 V... | Neostigmine Methylsulfate | Fresenius Kabi USA, LLC | 2015-01-08 |
| 63323-0413-36 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-36) / 10 mL in 1 V... | Neostigmine Methylsulfate | Fresenius Kabi USA, LLC | 2015-01-08 |
| 63323-0415-10 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-10) / 10 mL in 1 V... | Neostigmine Methylsulfate | Fresenius Kabi USA, LLC | 2015-01-08 |
| 63323-0415-36 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-415-36) / 10 mL in 1 V... | Neostigmine Methylsulfate | Fresenius Kabi USA, LLC | 2015-01-08 |
| 65145-0111-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-111-10) / 10 mL in 1... | Neostigmine Methylsulfate | Caplin Steriles Limited | 2021-04-30 |
| 65145-0112-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-112-10) / 10 mL in 1... | Neostigmine Methylsulfate | Caplin Steriles Limited | 2021-04-30 |
| 68083-0383-10 | 10 CARTON in 1 CARTON (68083-383-10) / 1 VIAL, MULTI-DOSE i... | Neostigmine methylsulfate | Gland Pharma Limited | 2019-10-21 |
| 68083-0384-10 | 10 CARTON in 1 CARTON (68083-384-10) / 1 VIAL, MULTI-DOSE i... | Neostigmine methylsulfate | Gland Pharma Limited | 2019-10-21 |
| 70069-0805-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (70069-805-10) / 10 mL in 1... | Neostigmine Methylsulfate | Somerset Therapeutics, LLC | 2022-01-10 |
| 70069-0806-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (70069-806-10) / 10 mL in 1... | Neostigmine Methylsulfate | Somerset Therapeutics, LLC | 2022-01-10 |
| 70121-1478-07 | 10 VIAL, MULTI-DOSE in 1 CARTON (70121-1478-7) / 10 mL in 1... | Neostigmine methylsulfate | Amneal Pharmaceuticals LLC | 2018-06-20 |
| 70121-1479-07 | 10 VIAL, MULTI-DOSE in 1 CARTON (70121-1479-7) / 10 mL in 1... | Neostigmine methylsulfate | Amneal Pharmaceuticals LLC | 2018-06-20 |
| 70594-0069-02 | 10 VIAL in 1 CARTON (70594-069-02) / 10 mL in 1 VIAL (70594... | Neostigmine Methylsulfate | Xellia Pharmaceuticals USA LLC | 2021-01-11 |
| 70594-0072-02 | 10 VIAL in 1 CARTON (70594-072-02) / 10 mL in 1 VIAL (70594... | Neostigmine Methylsulfate | Xellia Pharmaceuticals USA LLC | 2021-01-11 |
| 70700-0171-22 | 1 VIAL, MULTI-DOSE in 1 CARTON (70700-171-22) / 10 mL in 1... | Neostigmine methylsulfate | Xiromed LLC | 2020-09-09 |
| 70700-0171-23 | 10 VIAL, MULTI-DOSE in 1 CARTON (70700-171-23) / 10 mL in 1... | Neostigmine methylsulfate | Xiromed LLC | 2020-09-09 |
| 70700-0172-22 | 1 VIAL, MULTI-DOSE in 1 CARTON (70700-172-22) / 10 mL in 1... | Neostigmine methylsulfate | Xiromed LLC | 2020-09-09 |
| 70700-0172-23 | 10 VIAL, MULTI-DOSE in 1 CARTON (70700-172-23) / 10 mL in 1... | Neostigmine methylsulfate | Xiromed LLC | 2020-09-09 |
| 71288-0500-11 | 10 VIAL, MULTI-DOSE in 1 CARTON (71288-500-11) / 10 mL in 1... | neostigmine methylsulfate | Meitheal Pharmaceuticals Inc. | 2021-04-05 |
| 71288-0501-11 | 10 VIAL, MULTI-DOSE in 1 CARTON (71288-501-11) / 10 mL in 1... | neostigmine methylsulfate | Meitheal Pharmaceuticals Inc. | 2021-04-05 |
| 71839-0105-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (71839-105-10) / 10 mL in 1... | Neostigmine methylsulfate | BE Pharmaceuticals Inc. | 2022-03-17 |
| 71839-0105-24 | 24 CARTON in 1 CARTON (71839-105-24) / 1 VIAL, MULTI-DOSE i... | Neostigmine methylsulfate | BE Pharmaceuticals Inc. | 2019-05-13 |
| 71839-0106-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1... | Neostigmine methylsulfate | BE Pharmaceuticals Inc. | 2022-03-17 |
| 71839-0106-24 | 24 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE i... | Neostigmine methylsulfate | BE Pharmaceuticals Inc. | 2019-05-13 |
Observed labelers:
BE Pharmaceuticals Inc. (4) ·
Dr.Reddy's Laboratories Inc (4) ·
Fresenius Kabi USA, LLC (4) ·
Hikma Pharmaceuticals USA Inc. (4) ·
Xiromed LLC (4) ·
Amneal Pharmaceuticals LLC (2)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.